These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 18550537)

  • 1. Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy.
    Kabuta T; Furuta A; Aoki S; Furuta K; Wada K
    J Biol Chem; 2008 Aug; 283(35):23731-8. PubMed ID: 18550537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into links between familial and sporadic Parkinson's disease: physical relationship between UCH-L1 variants and chaperone-mediated autophagy.
    Kabuta T; Wada K
    Autophagy; 2008 Aug; 4(6):827-9. PubMed ID: 18635949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.
    Alvarez-Erviti L; Seow Y; Schapira AH; Rodriguez-Oroz MC; Obeso JA; Cooper JM
    Cell Death Dis; 2013 Mar; 4(3):e545. PubMed ID: 23492776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
    Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
    Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1.
    Kabuta T; Setsuie R; Mitsui T; Kinugawa A; Sakurai M; Aoki S; Uchida K; Wada K
    Hum Mol Genet; 2008 May; 17(10):1482-96. PubMed ID: 18250096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy.
    Cartier AE; Ubhi K; Spencer B; Vazquez-Roque RA; Kosberg KA; Fourgeaud L; Kanayson P; Patrick C; Rockenstein E; Patrick GN; Masliah E
    PLoS One; 2012; 7(4):e34713. PubMed ID: 22514658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of UCH-L1 on alpha-synuclein over-expression mouse model of Parkinson's disease.
    Yasuda T; Nihira T; Ren YR; Cao XQ; Wada K; Setsuie R; Kabuta T; Wada K; Hattori N; Mizuno Y; Mochizuki H
    J Neurochem; 2009 Feb; 108(4):932-44. PubMed ID: 19141079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders.
    Lee YC; Hsu SD
    Curr Protein Pept Sci; 2017; 18(7):733-745. PubMed ID: 26899237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease.
    Liu Z; Meray RK; Grammatopoulos TN; Fredenburg RA; Cookson MR; Liu Y; Logan T; Lansbury PT
    Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4635-40. PubMed ID: 19261853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lysosomal membrane protein LAMP2A promotes autophagic flux and prevents SNCA-induced Parkinson disease-like symptoms in the Drosophila brain.
    Issa AR; Sun J; Petitgas C; Mesquita A; Dulac A; Robin M; Mollereau B; Jenny A; Chérif-Zahar B; Birman S
    Autophagy; 2018; 14(11):1898-1910. PubMed ID: 29989488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease-associated mutations in α-synuclein and UCH-L1 inhibit the unconventional secretion of UCH-L1.
    Konya C; Hatanaka Y; Fujiwara Y; Uchida K; Nagai Y; Wada K; Kabuta T
    Neurochem Int; 2011 Aug; 59(2):251-8. PubMed ID: 21693148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal degradation of alpha-synuclein in vivo.
    Mak SK; McCormack AL; Manning-Bog AB; Cuervo AM; Di Monte DA
    J Biol Chem; 2010 Apr; 285(18):13621-9. PubMed ID: 20200163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chaperone-mediated autophagy markers in Parkinson disease brains.
    Alvarez-Erviti L; Rodriguez-Oroz MC; Cooper JM; Caballero C; Ferrer I; Obeso JA; Schapira AH
    Arch Neurol; 2010 Dec; 67(12):1464-72. PubMed ID: 20697033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C Virus NS5A Protein Promotes the Lysosomal Degradation of Hepatocyte Nuclear Factor 1α via Chaperone-Mediated Autophagy.
    Matsui C; Deng L; Minami N; Abe T; Koike K; Shoji I
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29695419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.
    McKeon JE; Sha D; Li L; Chin LS
    Cell Mol Life Sci; 2015 May; 72(9):1811-24. PubMed ID: 25403879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSM-900MHz at low dose temperature-dependently downregulates α-synuclein in cultured cerebral cells independently of chaperone-mediated-autophagy.
    Terro F; Magnaudeix A; Crochetet M; Martin L; Bourthoumieu S; Wilson CM; Yardin C; Leveque P
    Toxicology; 2012 Feb; 292(2-3):136-44. PubMed ID: 22185909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chaperone-mediated autophagy is defective in mucolipidosis type IV.
    Venugopal B; Mesires NT; Kennedy JC; Curcio-Morelli C; Laplante JM; Dice JF; Slaugenhaupt SA
    J Cell Physiol; 2009 May; 219(2):344-53. PubMed ID: 19117012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Parkinson's-disease-associated mutations on the deubiquitinating enzyme UCH-L1.
    Andersson FI; Werrell EF; McMorran L; Crone WJ; Das C; Hsu ST; Jackson SE
    J Mol Biol; 2011 Mar; 407(2):261-72. PubMed ID: 21251915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of chaperone-mediated autophagy in neurotoxicity induced by alpha-synuclein after methamphetamine exposure.
    Sun L; Lian Y; Ding J; Meng Y; Li C; Chen L; Qiu P
    Brain Behav; 2019 Aug; 9(8):e01352. PubMed ID: 31286692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.